baber/WOPTO huggingface dataset:
Patent NZ-526418-A (NZ)
Title: Pneumatic strapper with switchable transmission between one-way and two-way rotation
Inventor: NIX ROBERT J
IPC: B65B1/28
Filed: 2003-06-10
Abstract: The strapper has a weld motor and vibrating weld element connected to a piston so that strap ends can be joined to each other. A drive assembly connects a tensioning motor to a feed wheel and transmission cooperates with the drive assembly so as to be switchable between one-way rotation and two-way rotation of the drive assembly.
Patent NZ-527399-A (NZ)
Title: Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
Inventor: COFFEY MATTHEW C
IPC: A61K35/76
Filed: 2002-02-19
Abstract: Disclosed is the use of a reovirus in the manufacture of a medicament for sensitizing a ras-activated neoplastic cell to a chemotherapeutic agent in a patient in need thereof. Also disclosed is the use wherein the medicament comprises two pharmaceutical formulations suitable for sequential or concurrent administration, one of which contains a reovirus and other of which contains the chemotherapeutic agent. Further disclosed are methods for: sensitising a non-human ras-activated neoplastic cell to a chemotherapeutic agent; preventing a ras-activated neoplasm in a non-human subject from developing drug resistance to a chemotherapeutic agent; treating a non-human subject harbouring a ras-activated proliferative disorder wherein said subject comprises ras-activated neoplastic cells that are refractory ro a chemotherapeutic agent; preventing a ras-activated neoplasm in a non-human subject from developing drug resistance to a chemotherapeutic agent; and sensitising a ras-activated neoplastic cell ex vivo or in vitro to a chemotherapeutic agent.
Patent NZ-531063-A (NZ)
Title: 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
Inventor: CLARK MICHAEL PHILLIP
IPC: C07D491/113
Filed: 2002-09-20
Abstract: Disclosed are compounds of formula (I) wherein: R is -O[CH2]kR3 or -NR4aR4b wherein R3, R4a and R4b and k are as disclosed in the specification; R1 is substituted or unsubstituted aryl or heteroaryl; R2 is independently selected from H, (CH2)jO(CH2)nR8, -(CH2)jNR9aR9b, -(CH2)jCO2R10, -(CH2)jCO2R10, -(CH2)jCON(R10)2, -(CH2)jOCON(R10)2, two R2 units can together form a carbonyl unit, and mixtures thereof wherein R8, R9a, R9b, R10 and j are as described in the specification; Z is O, S, NR11 wherein R11 is H or C1-C4 alkyl. Compounds of the type disclosed are useful in controlling the extracellular release of inflammatory cytokines in humans and higher mammals.
Patent NZ-534452-A (NZ)
Title: Pharmaceutical composition containing formoterol and budesonide used in inhalers
Inventor: GOVIND NAYNA
IPC: A61P/
Filed: 2003-01-29
Abstract: A pharmaceutical composition that is suitable for treating respiratory disorders such as asthma, rhinitis and chronic obstructive pulmonary disease (COPD) is disclosed, wherein the composition comprises formoterol, budesonide, 1,1,1,2,3,3,3-heptafluoropropane (HFA 227), polyvinylpyrrolidone (PVP) and polyethylene glycol (PEG). These pharmaceutical compositions are suitable for use in a pressurised metered dose inhaler for treating the respiratory disorders.
Patent NZ-535725-A (NZ)
Title: A filter pit
Inventor: WADE RODNEY GEORGE
IPC: B01D29/23
Filed: 2004-10-04
Abstract: A filter pit is disclosed. The pit has an inlet and an outlet adjacent a base of the pit. A primary a secondary and a tertiary filter are located between the inlet and outlet and the tertiary filter is supported above the base and is able to dry out when the flow of the water through the pit ceases.
Patent NZ-536148-A (NZ)
Title: A method for repairing a protective lining of an industrial reaction or transport vessel
Inventor: BLISSENBACH DIETER
Filed: 2003-05-21
Abstract: A method for repairing a protective lining 2 of an industrial reaction or transport vessel 1, such as a converter vessel, electric arc furnace, or ladle is disclosed. The method includes the use of a measuring device 8 to identify combined areas of the lining that have a residual thickness below a predetermined threshold value. A processing unit 7 transforms the residual thickness data into binary data by comparing the measured residual thickness data with the pre-determined threshold value for the thickness of the lining. The processing unit then combines isolated areas of the lining having a thickness below the predetermined threshold value into combined areas of the lining to which a binary value for areas of the lining having a thickness below the pre-determined threshold value is assigned, and in a final step computes the position and repair sequence of each of the combined areas and transfers this data to a repair device 4. The repair device applies monolithic lining material onto the combined areas computed by the processing unit.
Patent NZ-540972-A (NZ)
Title: Novel 2,4-diamino-1,3,5-triazine derivative
Inventor: MAEDA SHIROU
IPC: A61Q17/00
Filed: 2003-12-16
Abstract: Dihydro-triazine derivative compounds of formula (I), tautomer thereof and a salt thereof are disclosed, wherein the variables are as defined in the specification. These compounds are suitable as antibacterial compounds and are useful for preparing an external bactericidal/disinfectant agent. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are also described.
Patent NZ-542494-A (NZ)
Title: Vascular stent
Inventor: GAZZA GIANLUCA
IPC: A61F2/82
Filed: 2003-05-22
Abstract: Disclosed is a stent comprising a coating based on a polymer of hyaluronic acid, wherein the said hyaluronic acid polymer is an ester derivative of hyaluronic acid, wherein all or some of the carboxyl groups of the hyaluronic acid are esterified with alcohols selected from those of the aliphatic, arylaliphatic, cycloaliphatic and heterocyclic series.
Patent NZ-543244-A (NZ)
Title: Method for the production of telmisartan (4'-[2-N-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazol-1-ylmethyl]biphenyl-2-carboxylic acid)
Inventor: HAUEL NORBERT
IPC: C07D403/02
Filed: 2004-03-26
Abstract: Disclosed is a process for preparing telmisartan, wherein (a) 2-N-propyl-4-methyl-6-(1'-methylbenzimidazol-2'-yl)-benzimidazole of formula (I) is reacted with a compound of general formula (IV), wherein Z denotes a leaving group, and the resulting compound is worked up, if desired, (b) the cyano group of the compound 2-cyano-4'-[2"-N-propyl-4"-methyl-6"-(1"'-methylbenzimidazol-2'"-yl)benzimidazol-1"-ylmethyl]biphenyl of formula (V) thus obtained is then converted by hydrolysis in water, in an organic solvent or in a mixture of an organic solvent with water in the presence of a base at temperatures between 80 and 200 deg C into the acid function.
Patent NZ-545471-A (NZ)
Title: Improvements in or relating to a protective casing component and an element for forming a protective casing component
Inventor: VANHENTENRIJK ROBERT
IPC: H02G15/076
Filed: 2004-09-03
Abstract: An optical fibre splice enclosure is disclosed. The enclosure includes a tubular housing which has an open end, a closed end, and a protective casing base component fitted to the open end of the housing. The base component has an opening through which a plurality of optical fibre cables can pass into and out of the enclosure, so that optical fibres may be spliced or connected to other optical fibres within the enclosure. The base component is formed of two semi-cylindrical parts, or of a single cylindrical element, having a wall which is at least partially flexible and/or resilient and which has a longitudinal slit or slot in the wall through which an intermediate part of an optical fibre cable can be passed laterally. The base component can be positioned or removed from a cable or plurality of cables at an intermediate point along their length without interrupting the continuity of the cables. The base component has means for sealing the interior of the enclosure from external agencies, and means for sealing the open end of the housing to the base component. The base component has (i) a generally radial flange at one end and two generally parallel longitudinal edges in the face of one of which there is an axially extending channel and in the face of the other of which there is a cooperating axially extending ridge which enters the channel when the base component is fitted together around the cables; and (ii) an annular skirt portion extending axially away from the radial flange to form a seat for a sealant gel between the base component and the open end of the housing. The axial channel in the face of one longitudinal edge communicates with the seat region defined by the radial flange and the annular skirt portion of the base component to allow a continuous bead of gel to extend around the annular region at the end of the base component and axially along the interface between the longitudinal edges thereof.
Patent NZ-549588-A (NZ)
Title: Directional flow sensor inhaler
Inventor: GUMASTE ANAND V
IPC: A61M15/02
Filed: 2005-02-23
Abstract: An inhaler is provided for delivering medicament to a user. The inhaler includes an acoustic controller which detects air flow around an acoustic sensing element and produces signals that identify the direction and amplitude of the air flow and a high frequency vibrator which induces the medicament into the air flow when the signals indicate inhalation by the user.
Patent NZ-549959-A (NZ)
Title: Multiple-variable dose regimen for treating TNFalpha-related disorders using anti TNFalpha antibodies
Inventor: GRANNEMAN GEORGE RICHARD
IPC: A61P37/00
Filed: 2005-04-11
Abstract: Disclosed is the use of an isolated human anti-TNFalpha antibody, or an antigen-binding fragment thereof, in the manufacture of a medicament for treating an intestinal disorder in which TNFalpha activity is detrimental using a multiple-variable dose regimen, said regimen, when used, comprising administering to a subject in need thereof at least one induction dose ranging from about 20 mg to about 200 mg of the human anti-TNFalpha antibody, or antigen-binding fragment thereof, such that a threshold level of the human anti-TNFalpha antibody, or antigen-binding fragment thereof, is achieved within an induction phase; and subsequently administering to the subject at least one treatment dose of the human anti-TNFalpha antibody, or antigen-binding fragment thereof which is 40-60% of the induction dose, within a treatment phase, such that treatment of the intestinal disorder occurs.
Patent NZ-550601-A (NZ)
Title: Combined meningococcal conjugates with common carrier protein
Inventor: CONSTANTINO PAULO
IPC: A61K47/48
Filed: 2005-04-29
Abstract: Disclosed is a composition for immunising a patient against a disease caused by Neisseria meningitidis, wherein the composition: (1) comprises conjugates for at least two of the four meningococcal serogroups A, C, W135 and Y, where at least two of the conjugates have a common carrier protein; and (2) includes the common carrier in an unconjugated form at less than 10 ìg/ml.
Patent NZ-551670-A (NZ)
Title: Combinations comprising antimuscarinic agents and corticosteroids
Inventor: GRAS ESCARDO JORDI
IPC: A61K31/167
Filed: 2005-05-31
Abstract: Disclosed is a combination of a corticosteroid and the M3 muscarinic receptor antagonist (3R)-1-phenethyl-3-(9H-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2]octane in the form of a salt with a pharmaceutically acceptable anion of a mono or polyvalent acid. Also disclosed is the use of the combination for treating asthma or chronic obstructive pulmonary disease (COPD).
Patent NZ-555108-A (NZ)
Title: Plumbing fitting such as wingback with body movable within mounting via key and keyway and serrations and catch for discrete positioning
Inventor: PICTON DAVID JOHN
IPC: F16L3/18
Filed: 2005-12-20
Abstract: A plumbing fitting includes a body portion 1 which is secured to a structure such as a wall framing in use by means of a mounting means 2. An inlet means 3 is linked to an outlet means 4 by means of an internal passage in the body portion. The inlet means is adapted to be secured to distributor pipework or hoses in use and the outlet means is adapted to be coupled to a flexible hose or a tap where it projects through a wall lining. The body portion 1 can slide within the mounting means 2 with body portion 1 having one or more key formation to slide within a complementary keyway formation or formations in the mounting means 2, if sufficient force is used, whereby serrations 19 can slide past projections in mounting means 2 (not shown) so that after the coupling is made to an extended outlet means 4 the outlet means can be pushed back towards the wall structure to assist in the provision of a neat appearance.
Patent NZ-562784-A (NZ)
Title: Methods for evaluating an immune response to a VLA-4 binding antibody
Inventor: SUBRAMANYAM MEENA
IPC: C07K16/28
Filed: 2006-04-04
Abstract: Disclosed is a method of detecting a reduction in therapeutic efficacy of a VLA-4 binding antibody in a subject that has been administered a VLA-4 binding antibody, the method comprising determining whether two or more biological samples taken at separate time points from the subject contain at least a threshold level of a soluble antibody that binds to the VLA-4 binding antibody, wherein the threshold level is at least two standard deviations above a control reference level of the soluble antibody, and wherein the presence of at least the threshold level of the soluble antibody in the two or more samples indicates a reduction of or absence of efficacy of the VLA-4 binding antibody in the subject. Further disclosed is a method of selecting a therapeutic regimen for a subject involving selecting a therapeutic regimen for the subject based on the assay results at the first and second time points.
Patent NZ-563133-A (NZ)
Title: Crystals of morphinan derivative and process for producing the same
Inventor: WAKITA HISANORI
IPC: A61K31/485
Filed: 2006-04-06
Abstract: Disclosed is a crystalline form of 17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[N-methyl-trans-3-(3-furyl)acrylamido]morphinan hydrochloride. Also disclosed is a process for producing the crystal of 17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[N-methyl-trans-3-(3-furyl)acrylamido]morphinan hydrochloride, which comprises reacting 17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[N-methyl-trans-3-(3-furyl)acrylamido]morphinan with hydrochloric acid in a good solvent, selected from methanol, ethanol and n-propanol, followed by mixing the reaction solution with a poor solvent selected from 2-propanol, 2-butanol and t-butanol, and stirring the mixture.
Patent NZ-570621-A (NZ)
Title: Vacuum cleaner nozzle with disposable cover sheet
Inventor: BARR CARL M
IPC: A47L9/04
Filed: 2008-08-19
Abstract: Disclosed is a vacuum cleaning apparatus which includes a base (10) with a source of suction and front and rear wheels (51, 52) for wheeling the base across a floor (6); a nozzle assembly (600) attached to and supported by the base, the nozzle assembly having a suction inlet (341, 342) and a sheet-pressing surface (361) that are located in front of the front wheels; and a disposable sheet (32) configured to be removably attached to the nozzle assembly. As the base is wheeled across the floor, the sheet-pressing surface presses the sheet against the floor to dislodge dirt from the floor, while the suction draws the dirt up from through the suction inlet.
Patent NZ-574072-A (NZ)
Title: 1-(beta-d-glucopyranosyl)-3-(4-cyclopropylphenylmethyl)-4-halogeno indole derivatives and use thereof as sglt inhibitors
Inventor: NOMURA SUMIHIRO
IPC: A61K31/706
Filed: 2007-07-27
Abstract: Disclosed are compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 is fluorine, or chlorine, and R2 is hydrogen, or fluorine, protected forms thereof and processes for their preparation. The compounds are SGLT inhibitors and are useful for treatment or prevention of diabetes and related conditions.
Patent NZ-574520-A (NZ)
Title: Use of casein which is at least 10% dephosphorylated for the treatment of diseases and conditions mediated by increased phosphorylation
Inventor: BAR-OR DAVID
IPC: A61K38/08
Filed: 2003-11-25
Abstract: Disclosed is a pharmaceutical composition comprising casein or a functional fragment thereof which is at least 10% dephosphorylated and a pharmaceutically acceptable carrier. Further disclosed is the use of the pharmaceutical composition in the manufacture of a medicament for treating a disease or condition mediated by increased phosphorylation.
Patent NZ-580863-A (NZ)
Title: Fire collar for floor waste drain having adjustable outer housing
Inventor: PORTER RAY
IPC: A62C2/06
Filed: 2008-06-13
Abstract: Disclosed is a floor waste drain fire collar to prevent egress of smoke and fire between floors in a multi-story building. The fire collar (58) has an outer housing (70) with a upper puddle flange (76) and a removable sealing cap (78) in the upper flange, a tubular body (80) is received in the outer housing and is movable longitudinally within the outer housing from a position in which it is received within the outer housing to a position in which an upper end of the tubular body extends beyond the outer housing. The tubular body has a valve seat (86) and a valve assembly (88). The valve assembly has a valve member which in a first position allows flow through the flow path and a second position in which it is engaged against the valve seat to prevent flow through the tubular body. The valve assembly includes an intumescent material (90). A fusible link (100) maintains the valve member in the first position against a spring force (102) whereby when the fusible link has been heated above a selected temperature by a fire the valve member to the second position to prevent smoke and fire passing through the floor waste fire collar.
Patent NZ-583118-A (NZ)
Title: A winding mechanism for a window blind with open and closed positions for attaching the pull cord
Inventor: LICCIARDI DI STEFANO CARMELO JOSEPH
IPC: E06B9/42
Filed: 2010-02-05
Abstract: A winder for a window blind is disclosed. The winder opens up to allow the easy installation of a winding cord. The winder includes a support with a wall portion (208) and a spindle as well as a housing (106) rotatably mounted onto the spindle. The housing (106) has a drive portion (204) for receiving a cord that controls the rotation of the housing (106 ) for extending and retracting a blind. The housing (106) is selectively moveable along the spindle between an open position and a closed position, such that when the housing is placed in the open position, the drive portion (204) is exposed for receiving the cord, and when the housing is placed in the closed position, the wall (208) portion covers at least a part of the drive portion (204) to resist disengagement of the entire cord from the drive portion (204).
Patent NZ-583215-A (NZ)
Title: A strainer post assembly comprising a brace, a slidable brace platform, a stay and a locking assembly
Inventor: WADE ROBERT ANDREW
IPC: E04H17/06
Filed: 2011-02-07
Abstract: A strainer post assembly (1) is disclosed. The assembly (1) comprises a brace (6), a brace platform (7), a stay (4) and a locking assembly. The brace (6) connects to a post (2) and the brace platform (7) accepts the brace (6) such that brace platform (7) can slide along the brace (6). One end of the stay (4) is connected to the post (2) and the other end is slidably connected to the brace platform (7). The locking assembly includes a locking member (16) having an aperture (17) that is configured to accept the brace (6) such that the locking member (16) can slide along the brace (6) from a first position. The locking member (16) is located relative to the brace platform (7) such that sliding the stay (4) in relation to the brace platform (7) applies force to the locking member (16) to move it to a second position that is inclined with respect to the first position. In the second position the locking member (16) is held in a fixed location with respect to the brace (6) and grips the brace (6), locking the brace platform (7) in place and maintaining a rigid relationship between the post (2), stay (4) and brace (6)
Patent NZ-588356-A (NZ)
Title: Gate valve with a gate that can be moved linearly to open and close the gate and including an equaliser port
Inventor: PALMER MICHAEL J
IPC: F16K3/02
Filed: 2009-04-09
Abstract: 588356 Disclosed is a gate valve (10) with an equaliser port (110). The valve has a main gate (12) defining a main gate passageway (14) and movable between opened and closed positions within a valve body (16). In the opened position the main gate passageway (14) is aligned with walls defining main passageways (18) in the valve body (16) on opposite sides of the gate (12) to enable flow through the valve (10). In the closed position external sealing faces (22) of the main gate (12) are aligned with the main passageways (18) in the valve body (16), to prevent flow through the valve (10) in cooperation with seals (26) between the gate (12) and the valve body (16). The valve (10) has an interior cavity formed within the gate (12) and having opposing internal faces. The valve (10) further has an equalizer gate shiftable in a linear direction within the interior cavity. The valve (10) has a gate equalizer port (110) defined through the each of the external sealing faces (22) of the gate (12) for enabling communication of fluid across the gate (12) when aligned with an internal equalizer port formed in the equalizer gate when the equalizer gate is in an open position.
Patent NZ-590802-A (NZ)
Title: Formulation comprising a pyrazolone derivative and an amphiphilic solubilising agent
Inventor: NABETA KIICHIRO
IPC: A61K38/00
Filed: 2009-11-18
Abstract: 590802 Pyrazolone derivative formulations are provided. The formulations include a pyrazolone derivative active agent, e.g., edaravone, and an amphiphilic solubilizing agent. Also provided are methods of making and using the subject formulations.
Patent NZ-591684-A (NZ)
Title: Glow in the dark buoyant articles comprising inorganic photoluminescent material distributed through a polymer
Inventor: ROGERS BARRY
IPC: B63C9/08
Filed: 2009-08-07
Abstract: 591684 Disclosed is a glow in the dark buoyant article comprising a polymer containing particles of a photoluminescent material having a particle size of between 10 microns and 250 microns distributed throughout the polymer wherein: the polymer is selected from the group consisting of polyolefins, polyurethanes, acrylic polymers, polycarbonates and combination or copolymers thereof, the photoluminescent material is a rare-earth doped alkali and/or alkaline earth metal aluminate, alumino-silicate, alumino-phosphate or aluminophospho-silicate, with optional halogenation; and the amount of photoluminescent material incorporated into the polymer is between 9 and 12 per cent by weight of the polymer.
Patent NZ-592044-A (NZ)
Title: Evisceration conveyor with two horizontal conveyors between two locations where the receivers transfer from one conveyor to the other at each location
Inventor: SUTHERLAND JOHN
IPC: A22B7/00
Filed: 2011-04-01
Abstract: An evisceration conveyor 10 comprises a first conveyor 11 driven by a first drive mechanism for driving a plurality of product receivers 13 in a substantially horizontal direction from a first position to a second position, and a second conveyor 12 driven by a second drive mechanism for driving the plurality of product receivers 13 substantially horizontally from the second position to the first position. The product receivers 13 are adapted to transition from the first conveyor 11 to the second conveyor 12 at the second position and from the second conveyor 12 to the first conveyor 11 at the first position.